Cargando…
Erratum to “A two-microRNA signature predicts the progression of male thyroid cancer”
Autores principales: | Liu, Bingyang, Shi, Haihong, Qiu, Weigang, Wu, Xinquan, Li, Liqiong, Wu, Wenyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462541/ https://www.ncbi.nlm.nih.gov/pubmed/36133423 http://dx.doi.org/10.1515/biol-2022-0083 |
Ejemplares similares
-
A two-microRNA signature predicts the progression of male thyroid cancer
por: Liu, Bingyang, et al.
Publicado: (2021) -
ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma
por: Qiu, Weigang, et al.
Publicado: (2022) -
Erratum: Relationship Between MicroRNA Signature and Arterial Stiffness in Patients With Ischemic Stroke
por: Lee, Sang-Jin, et al.
Publicado: (2023) -
Erratum to: Regenerative medicine in orthopedics using cells, scaffold, and microRNA
por: Ochi, Mitsuo, et al.
Publicado: (2014) -
Erratum to: ‘MicroRNA target prediction using thermodynamic and sequence curves’
por: Ghoshal, Asish, et al.
Publicado: (2016)